Showing results (1-10 of 125) with videos related to
Sort By:
Pageof 13
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Activation-induced cell death limits effector function of CD4 tumor-specific T cellsRebecca R Saff, Elena S Spanjaard, Andreas M Hohlbaum, et al.Clinical Immunology (Orlando, Fla.)|May 4, 2002
Fas-ligand--iron fist or Achilles' heel?Andreas M Hohlbaum, Rebecca R Saff, Ann Marshak-RothsteinCancer Research|December 20, 2007
Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligandMeredith S Gregory, Rebecca R Saff, Ann Marshak-Rothstein, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
Membrane Fas ligand activates innate immunity and terminates ocular immune privilegeMeredith S Gregory, Amanda C Repp, Andreas M Holhbaum, et al.Investigative Ophthalmology & Visual Science|June 28, 2005
A novel treatment for ocular tumors using membrane FasL vesicles to activate innate immunity and terminate immune privilegeMeredith S Gregory, Sean Koh, Eric Huang, et al.Nature|April 12, 2002
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptorsElizabeth A Leadbetter, Ian R Rifkin, Andreas M Hohlbaum, et al.Nature Reviews. Immunology|October 26, 2006
Toll-like receptors in systemic autoimmune diseaseAnn Marshak-RothsteinToxicological Sciences : an Official Journal of the Society of Toxicology|August 18, 2004
Early consequences of 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on the activation and survival of antigen-specific T cellsCastle J Funatake, Erica A Dearstyne, Linda B Steppan, et al.Current Opinion in Immunology|January 31, 2025
Nucleic acid triggers of autoimmunity and autoinflammationKaiyuan Hao, Ann Marshak-RothsteinPageof 13